VASSPRVasopressin for Septic Shock Pragmatic Trial
Vasopressin
+ Recommendation to use a higher initiation threshold for vasopressin
+ Recommendation to use a lower initiation threshold for vasopressin
Urogenital Diseases+14
+ Diabetes Insipidus
+ Endocrine System Diseases
Treatment Study
Summary
Study start date: February 1, 2024
Actual date on which the first participant was enrolled.Septic shock is a dangerous condition where severely low blood pressure results from a serious infection. Treating septic shock usually involves medications called vasopressors that help raise blood pressure. In some cases, the initial vasopressor medications may not work well enough, leading doctors to add another medication called vasopressin. However, it is not clear at what point this additional medication should be started. This study is important because it aims to compare two strategies for using vasopressin in treating septic shock, helping to determine the best approach to improve patient outcomes. In this study, participants will be treated with standard first-line vasopressors and then, based on the strategy being tested, vasopressin will be added either at a lower or higher threshold of blood pressure. The trial is designed to compare these two approaches by seeing which one better supports blood pressure in septic shock patients. Although the trial does not specify risks or benefits, understanding the optimal timing for adding vasopressin could lead to better treatment protocols and potentially improve survival rates for those with septic shock.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.2050 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Active ComparatorGroup II
Active ComparatorStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 13 locations
American Fork Hospital
American Fork, United StatesCedar City Hospital
Cedar City, United StatesLayton Hospital
Layton, United States